Chimeric Antigen Receptor T-Cell Therapy in Dialysis-Dependent Patients With Multiple Myeloma: Insights From a 5-Case Series

Chimeric antigen receptor (CAR) T-cell therapy has emerged as a transformative treatment for multiple hematologic malignancies, including multiple myeloma. However, patients with advanced chronic kidney disease, particularly those who are dialysis-dependent, have generally been excluded from clinica...

Descripción completa

Detalles Bibliográficos

Autores principales:	Varsha Swamy, Kaitlin Kelly, Jay L. Koyner, Benjamin A. Derman, Marco Bonilla
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	Elsevier 2025-12-01
Colección:	Kidney Medicine
Materias:	Kidney failure CAR T-cell therapy dialysis dependent multiple myeloma AKI lymphodepleting regimen
Acceso en línea:	http://www.sciencedirect.com/science/article/pii/S2590059525001773
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!